Doppel Farmaceutiche S.r.l. (manufacturer of finished medicinal product, primary packaging, secondary packaging, quality control, batch release)
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of adults and children with hereditary tyrosinemia type 1 (provided a special diet is followed) and adult patients with alkaptonuria.
Dosage form: capsules, hard
Active substance Dosage nitizinoine 2 mg ATC: A16AX04
-
The drug is intended for the treatment of adults and children with hereditary tyrosinemia type 1 (provided a special diet is followed) and adult patients with alkaptonuria.
Dosage form: capsules, hard
Active substance Dosage nitizinoine 5 mg ATC: A16AX04
-
The drug is used for the treatment of adults and children with hereditary tyrosinemia type 1 (provided a special diet is followed), as well as for the treatment of adult patients with alkaptonuria.
Dosage form: capsules, hard
Active substance Dosage nitizinoine 10 mg ATC: A16AX04